Related by context. All words. (Click for frequent words.) 64 percutaneous drainage 64 intraoperative complications 63 somatosensory evoked potentials 62 pulmonary artery banding 62 resection cavity 62 transabdominal 61 myocardial revascularization 61 pulmonary resection 61 thyroid carcinoma 61 nephrectomies 61 pathologic diagnosis 61 transthoracic 61 pretransplant 60 sonographic appearance 60 carotid stenosis 60 sonographically guided 60 Coronary artery bypass graft 60 preoperative diagnosis 60 postoperative infections 60 transcatheter closure 60 postoperative morbidity 60 immunosuppression therapy 60 neurosensory 60 oncologic outcomes 60 ultrasonographic 60 corneal thickness 60 pulmonary dysfunction 59 tissue oxygenation 59 clinicopathologic 59 leiomyomas 59 urodynamic parameters 59 transrectal ultrasound 59 cerebral oxygenation 59 endoscopic ultrasonography 59 transesophageal echocardiography 59 vesicoureteral reflux VUR 59 underwent coronary angiography 59 extracranial 59 postoperative complication 59 electrophysiologic 59 calcaneal fractures 59 urolithiasis 59 osteoporotic compression fractures 59 transrectal ultrasound guided 59 β blockers 59 osteoid osteoma 59 prospective multicenter study 59 Preoperatively 59 percutaneous vertebroplasty 59 adenoidectomy 59 intravesical therapy 59 endoscopic retrograde 59 ovarian malignancy 59 atrioventricular block 59 angiographically 59 pre operatively 59 LAGB 59 malignant neoplasms 59 femoral neck fracture 59 colostomy ileostomy 58 chest radiographs 58 preoperative evaluation 58 carotid revascularization 58 bronchoalveolar lavage BAL 58 adenomatous 58 Adenomas 58 BPS IC 58 histologic examination 58 spinal metastases 58 cerebral angiography 58 tracheal intubation 58 sonographic findings 58 voiding dysfunction 58 duplex ultrasonography 58 adnexal mass 58 radiographic findings 58 thymectomy 58 myomas 58 renal scarring 58 conventional angiography 58 endobronchial 58 thoracoscopic lobectomy 57 neurologic outcomes 57 metaplasia 57 crossclamp 57 colorectal adenocarcinoma 57 angioplasty stent 57 coronary revascularization 57 immunocompetent 57 renal biopsy 57 gynecologic procedures 57 esophagogastroduodenoscopy 57 haematologic 57 tissue perfusion 57 renal cysts 57 mediastinitis 57 arthrography 57 hydronephrosis 57 transvaginal sonography 57 urodynamic 57 hepatorenal syndrome 57 sinonasal 57 psychiatric comorbidities 57 pharmacodynamic parameters 57 colonoscopic 57 cervicitis 57 adverse cytogenetics 57 carotid angioplasty 57 treat brain aneurysms 57 carotid artery stent 57 meniscectomy 57 mucinous 57 cytologic 57 intima media thickness 57 TURBT 57 sonographic diagnosis 57 interobserver 57 endometrial biopsies 57 pathologic examination 57 retransplantation 57 Cardiopulmonary bypass 57 revascularization procedures 57 perioperative mortality 57 sacral nerve stimulation 57 angiographic outcomes 57 autologous SCT 57 endovascular aneurysm repair EVAR 57 aortic root replacement 56 hyperoxaluria 56 bronchogenic carcinoma 56 myocardial viability 56 sonographically 56 renal allograft 56 intracranial hemorrhage ICH 56 carotid plaque 56 prospectively enrolled 56 histological subtype 56 florbetaben 56 mesangial 56 ultrasonographic examination 56 rebleeding 56 nodal metastasis 56 lipid lowering agents 56 echocardiographic parameters 56 epididymitis 56 serologic tests 56 intracranial stenosis 56 TKAs 56 immunochemical fecal occult 56 VATS lobectomy 56 hepatic insufficiency 56 syndromic 56 LVNC 56 carotid artery stenting CAS 56 vesicoureteral reflux 56 lung resection 56 metastatic neuroendocrine tumors 56 laparoscopically assisted 56 bone scintigraphy 56 risk reducing salpingo 56 hemodynamic measurements 56 arteriography 56 Fully Covered Stent 56 oncological outcomes 56 urethral stricture 56 perfusion abnormalities 56 percutaneous biopsy 56 GH deficiency 56 oral anticoagulation 56 malignant polyps 56 nonoperative treatment 56 NMIBC 56 HER2 expression 56 transurethral 56 transthoracic echocardiography 56 proton MR spectroscopy 56 anagrelide 56 Catheter Associated 56 catheter angiography 56 differential gene expression 56 skeletal metastases 56 postprocedure 56 cerebral perfusion 56 stratifying patients 56 atherosclerotic renal artery stenosis 56 pulmonary angiography 55 CTEPH 55 liver metastasis 55 carotid IMT 55 histologic subtype 55 foveal thickness 55 nondiagnostic 55 EuroSCORE 55 esophagogastric 55 cystoscopic 55 diabetic polyneuropathy 55 carotid endarterectomy CEA 55 symptomatic paroxysmal AF 55 body habitus 55 nonoperative 55 incomplete revascularization 55 antiplatelet medications 55 coexisting illnesses 55 CT perfusion 55 postoperative AF 55 hematological parameters 55 LV ejection fraction 55 IVDs 55 Coronary artery bypass grafting 55 AGHD 55 hyperacute 55 HIPEC 55 cerebral oximetry 55 hemorrhagic complications 55 perioperative complications 55 diagnostic modality 55 esophageal carcinoma 55 FluCAM arm 55 intraobserver 55 radionuclide imaging 55 allograft rejection 55 cerebral microbleeds 55 tumor histology 55 parenteral antibiotics 55 postdischarge 55 CIMZIA TM certolizumab pegol 55 pituitary adenomas 55 malabsorptive 55 subtrochanteric 55 oral anticoagulant therapy 55 CT angiograms 55 decubitus ulcers 55 plain radiographs 55 serologic testing 55 primary hyperparathyroidism 55 colorectal liver metastases 55 Afib 55 electrode arrays 55 endoscopic examinations 55 renal tumors 55 ß blockers 55 etiologic 55 chronic LBP 55 neurologic abnormalities 55 nodal metastases 55 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 55 prognostic variables 55 follicular thyroid cancer 55 SLNB 55 FFR measurements 55 antimicrobial prophylaxis 54 cytogenic 54 functional mitral regurgitation 54 treated nonsurgically 54 Minimally invasive surgery 54 malignant nodules 54 electroencephalographic 54 comorbid diagnoses 54 Papillary 54 TRUS 54 adenomatous polyps 54 hematopoietic cancers 54 clinicopathological features 54 BSIs 54 Hurthle cell 54 psychiatric comorbidity 54 cytological 54 adenotonsillectomy 54 symptomatic benign prostatic 54 perioperative morbidity 54 hematopoietic malignancies 54 arterial revascularization 54 urothelial carcinoma 54 asplenia 54 cytogenetic abnormalities 54 malignant ascites 54 liver resection 54 euthyroid 54 spirometric 54 Pelvic Organ Prolapse 54 fundus photography 54 ALI ARDS 54 unicompartmental knee arthroplasty 54 Infusion Reactions Severe 54 Coronary CTA 54 dosimetric 54 hyper IgE syndrome 54 squamous intraepithelial lesions 54 CIN2 + 54 extramedullary 54 renal cell carcinomas 54 bioprosthetic valve 54 symptomatic VTE 54 Hypotension 54 Complication rates 54 percutaneous cryoablation 54 cervical lymph nodes 54 adnexal masses 54 overactive bladder syndrome 54 TLIF 54 recurrent glioblastoma multiforme 54 prospectively stratified 54 radiculopathy 54 bronchoscopic procedure 54 BPH LUTS 54 adolescent idiopathic scoliosis 54 comorbid depression 54 ICD shocks 54 urine cytology 54 pretest probability 54 renal denervation 54 Histologic 54 paclitaxel eluting stents 54 Surgical resection 54 DXA scan 54 thromboprophylaxis 54 symptomatic carotid stenosis 54 Venous thromboembolism 54 RARP 54 vertebral compression fracture 54 postsurgical 54 Tumor Response 54 endometrial biopsy 54 thromboembolic disease 54 nomograms 54 recurrent DVT 54 antiphospholipid antibodies 54 aromatase inhibitor therapy 54 prostate abnormalities 54 neurologic complications 54 multivessel disease 54 transient elastography 54 scintigraphic 54 R0 resection 54 AFRS TM 54 antiangiogenic therapy 54 somatostatin analogues 54 perioperatively 54 transcranial Doppler ultrasound 54 Peripheral Arterial 54 VTE prophylaxis 54 gastric adenocarcinoma 54 multivariable analyzes 54 AV fistula 54 haematological 54 engineered urethras 54 LV dysfunction 54 malignant lymphomas 54 HER2 amplification 54 bowel resection 54 moderately emetogenic 54 ophthalmoscopy 54 serum calcium levels 53 cervical lymph node 53 FDG PET imaging 53 pelvic ultrasound 53 adjuvant therapies 53 unruptured aneurysm 53 tumor necrosis 53 polyposis 53 GIST tumors 53 comorbid conditions 53 STRIDE PD 53 endovascular interventions 53 allogeneic hematopoietic stem cell 53 surgical revascularization 53 lumbosacral spine 53 Meta analyzes 53 laparoscopic partial nephrectomy 53 chronic periodontitis 53 normal karyotype 53 prostatic hyperplasia 53 obscure gastrointestinal bleeding 53 enterococcal 53 metastatic malignant 53 atherothrombotic 53 surgically resected 53 percutaneous intervention 53 renoprotective 53 epidural steroid injection 53 % CI #.#-#.# [005] 53 guideline concordant 53 T1DM 53 Diastolic Heart Failure 53 transcranial Doppler 53 myofibroblasts 53 debulking surgery 53 coronary revascularization procedures 53 intrapartum 53 Cardiac catheterization 53 extracapsular extension 53 Nephrogenic Systemic Fibrosis 53 MS DRG 53 multicenter clinical trials 53 computed tomographic scan 53 biliary tract cancer 53 venous thromboembolic disease 53 glycoprotein IIb IIIa inhibitors 53 interobserver reliability 53 variceal bleeding 53 radical prostatectomy RP 53 Histological 53 IGRAs 53 myeloproliferative diseases 53 bivariate analyzes 53 haematopoietic stem cell 53 indications contraindications 53 tumoral 53 postoperative chemotherapy 53 antithrombotic therapy 53 postoperative mortality 53 selective agonists 53 extracolonic findings 53 chemoembolization 53 histologically proven 53 estimated GFR 53 urodynamic studies 53 graft occlusion 53 hemodynamic variables 53 hip resurfacing arthroplasty 53 metabolite concentrations 53 pleural fluid 53 haemodynamic 53 AST ALT 53 morphometric vertebral fractures 53 multivariate regression analysis 53 peripheral arterial 53 IPAH 53 carotid artery narrowing 53 diagnostic angiography 53 cardiac perfusion 53 patients undergoing CABG 53 genomic biomarker 53 candidemia 53 periprocedural 53 cochlear implantation 53 poor metabolizers 53 neurocognitive impairment 53 clevidipine 53 cerebral vasospasm 53 Diabetic Foot Ulcer 53 affective psychosis 53 pulmonary artery catheterization 53 diagnostic coronary angiography 53 bronchoscopies 53 myeloperoxidase 53 obstructive CAD 53 clefting 53 stem cell transplantations 53 coronary stenoses 53 unresectable tumors 53 waist circumference WC 53 neoplasias 53 chorioamnionitis 53 pharmacologic stress 53 interrater 53 antiphospholipid syndrome 53 antibiotic regimens 53 clinico pathological 53 core needle biopsy 53 multivariate analyzes 53 cranial irradiation 53 gastric carcinoma 53 allogeneic HSCT 53 endoscopist 53 pharmacologic treatments 53 intestinal metaplasia 53 Post operatively 53 eosinophilic pneumonia 52 preoperatively 52 benign neoplasms 52 HGPIN 52 paragangliomas 52 histopathologic examination 52 histopathologic 52 papillary carcinoma 52 graft patency 52 submucosal 52 cytoreductive surgery 52 MTWA testing 52 buprenorphine implants 52 treat enlarged prostate 52 Coronary Artery Bypass Graft 52 NSQIP 52 antiplatelet drugs 52 HbA 1c levels 52 miRview squamous 52 NATRECOR ® 52 pathologic correlation 52 cardiopulmonary bypass surgery 52 papillary renal cell carcinoma 52 glial tumors 52 unexplained mental retardation 52 laparoscopic radical nephrectomy 52 pT2 52 Optical coherence tomography 52 causative mutation 52 ADVEXIN therapy 52 neurologic sequelae 52 solar keratoses 52 hoFH 52 proliferative retinopathy 52 BrachySil TM 52 intravascular hemolysis 52 hepatic metastases 52 hemostatic efficacy 52 RNFL thickness 52 benign uterine 52 prostate carcinoma 52 transrectal ultrasonography 52 GnRH agonists 52 perfusion MRI 52 sleeve lobectomy 52 thyroid carcinomas 52 myelodysplastic myeloproliferative diseases 52 extrapulmonary 52 everolimus eluting stents 52 HSCT 52 mean ± SEM 52 perinatal outcomes 52 osteoporotic vertebral compression fractures 52 eculizumab therapy 52 mammographically 52 procedural sedation 52 venous thromboembolism prophylaxis 52 trypsin digestion 52 biliary stones 52 CORE OM 52 Vascugel ® 52 treat chronic sinusitis 52 graft dysfunction 52 polycythemia vera essential thrombocythemia 52 papillary thyroid carcinoma 52 Squamous 52 DCE MRI 52 chronic myocardial ischemia 52 neurocognitive outcomes 52 ICSs 52 HER2 overexpression 52 intact parathyroid hormone 52 ergot alkaloids 52 T1a 52 OnDose TM 52 hemodynamic parameters 52 multivariable analysis 52 PSGs 52 MitraClip device 52 uncorrected visual acuity 52 NMDA antagonists 52 osteogenic 52 postoperative atrial fibrillation 52 epithelial tumors 52 thyroid nodules 52 vasoactive 52 interstitial brachytherapy 52 DVT PE 52 chronic GVHD 52 antithrombotic agents 52 nephron sparing surgery 52 poststroke 52 postoperative radiotherapy 52 tumorigenicity 52 Cytogenetic 52 neuropsychological impairments 52 polycythemia vera PV 52 dysrhythmias 52 recanalization 52 plasma pharmacokinetics 52 HBV infections 52 EPDS 52 vWD 52 preoperative PSA 52 Circulating tumor cells 52 HIV seropositive 52 coagulation disorders 52 microalbumin 52 baseline LDH 52 obstructive coronary artery 52 cystic fibrosis chronic pancreatitis 52 Echocardiographic 52 busulfan 52 aneuploidy screening 51 psychiatric morbidity 51 interrater reliability 51 Severe Primary IGFD 51 sonographic examinations 51 NIHSS score 51 Renal Cell Carcinoma RCC 51 hyperbilirubinemia 51 comorbid disorders 51 exploratory endpoints 51 Cardiorespiratory fitness 51 Injury Severity Score 51 inflammatory biomarkers 51 meta regression 51 resynchronization therapy 51 pathologic fractures 51 laparoscopic nephrectomy 51 humoral responses 51 ELBW infants 51 mutated K ras 51 histopathologic diagnosis 51 MGuard ™ 51 transplantation HCT 51 immunohistochemical analysis 51 total thyroidectomy 51 refractive correction 51 coronary catheterization 51 Computed Tomographic 51 G CSFs 51 undergoing coronary angiography 51 epidural analgesia 51 atherogenic dyslipidemia 51 therapeutic regimens 51 HES CEL 51 ano genital warts 51 unfavorable cytogenetics 51 drug eluting stent implantation 51 serological tests 51 extrapyramidal symptoms 51 Neo Bladder Augment 51 upper aerodigestive tract 51 DEXA scans 51 haematopoietic 51 Primary endpoints 51 immunosuppressant therapy 51 invasive carcinomas 51 lymphocytosis 51 cosmesis 51 Comorbidities 51 neoplastic 51 malignant lymph nodes 51 de novo AML 51 von Willebrand 51 ductal breast cancer 51 visceral metastases 51 monoclonal gammopathy 51 thrombotic complications 51 myocardial function 51 diabetes mellitus DM 51 preoperative intraoperative 51 p# biomarker 51 maturational 51 LRTI 51 posttransplant 51 treating neuropathic pain 51 sacrocolpopexy 51 ischemic cardiomyopathy 51 BEXXAR Therapeutic Regimen 51 elevated bilirubin 51 T2DM 51 multimodality therapy 51 Contraindications 51 thromboembolic complications 51 gonococcal 51 cytomegalovirus infection 51 multisystemic 51 colorectal carcinomas 51 pulmonary capillary wedge 51 acetonide FA 51 prehospital setting 51 Multivariable logistic regression 51 induced sputum 51 antiarrhythmic drug 51 Skin sterol 51 CsA 51 Histopathologic 51 IntroductionThe 51 Histopathological 51 microsatellite instability 51 enzyme immunoassay EIA 51 troponins 51 cervical cerclage 51 HIV HCV coinfected 51 shorter telomere length 51 liver histology 51 prostate cancer CaP 51 fallopian tube cancers 51 CRVO 51 allogeneic stem cell 51 patellofemoral pain syndrome 51 Capsule endoscopy 51 thrombus aspiration 51 periprocedural MI 51 hepatic lesions 51 hormone receptor negative 51 abnormal lipid 51 platelet reactivity 51 mediastinal lymph nodes 51 catheter ablations 51 opioid dependent 51 NHAMCS 51 metastatic GIST 51 tonsillar hypertrophy 51 Venous stasis ulcers 51 Ultrasonographic 51 antibiotic prophylaxis 51 Prolapse 51 GEM OS1 51 hyperplasia BPH 51 electromechanical coupling 51 relapsed MM 51 dosage regimens 51 genotypic resistance 51 virtual colonography 51 circulating endothelial cells 51 #beta estradiol 51 pCR 51 Diabetic Neuropathy 51 Hair follicle 51 histopathological examination 51 infiltrating ductal carcinoma 51 sirolimus eluting stents 51 certolizumab 51 ICD CRT 51 Genetic variants 51 chemosensitivity 51 VLBW 51 mechanistic studies 51 Iron Deficiency Anemia 51 Acute renal failure 51 etiologic factors 51 neurodevelopmental outcome 51 core needle biopsies 51 adjuvant systemic 51 erythropoietic 51 benign prostatic hypertrophy 51 allogeneic hematopoietic cell 51 medication nonadherence 51 Zevalin consolidation 51 advanced adenoma 50 Bacteremia 50 atherothrombosis 50 follicular lymphoma FL 50 NMES 50 meta analytic 50 endoscopic resection 50 lymphoproliferative disorders 50 warfarin dosage 50 narrow QRS 50 neuromotor 50 somatic complaints 50 Multivariate analysis 50 Liver biopsy 50 FDG-PET/CT 50 Multivariate logistic regression 50 phototoxicity 50 lymphomas leukemias 50 multivariate regression 50 DSM IV diagnoses 50 radiographic outcomes 50 PNH patients 50 Achilles tendon ruptures 50 Cerashield TM 50 neurodevelopmental outcomes 50 hypereosinophilic syndrome 50 surrogate markers 50 smoldering multiple myeloma 50 aldosterone antagonist 50 recurrent venous thromboembolism 50 prognostic indicators 50 neurocognitive deficits 50 anti androgens 50 non selective NSAIDs 50 obstetric ultrasound 50 Comorbidity 50 antiepileptics 50 somatic symptoms 50 MYCAMINE 50 Secondary efficacy endpoints 50 levodopa induced 50 pressure monitoring ABPM 50 NNT = 50 methotrexate therapy 50 cardiac repolarization 50 MACCE 50 lymphovascular invasion 50 Accelerated Partial Breast Irradiation 50 coronary anatomy 50 inhospital mortality 50 Charlson comorbidity index 50 antireflux surgery 50 multimodality imaging 50 postoperative pulmonary 50 serum lipid levels 50 QTc intervals 50 rectovaginal 50 nephrotoxicity 50 relapsed ALL 50 monofocal 50 coronary CTA 50 FENO 50 colposcopic 50 ipsilateral stroke 50 genitourinary cancers 50 peri procedural 50 serum lipid 50 ALT flares 50 bronchopulmonary dysplasia BPD 50 dyssynchrony 50 comorbid illnesses 50 VP# [004] 50 psychotherapeutic interventions 50 Retreatment 50 extrapleural pneumonectomy 50 pamidronate 50 Hematologic 50 RUGs IV 50 eTag assays 50 ASR XL 50 MPNs 50 audiometric 50 overnight polysomnography 50 CMV reactivation 50 thrombo embolic 50 pelvic lymph node dissection 50 refractory angina 50 bronchopulmonary 50 HRQL 50 inflammatory rheumatic 50 acute GvHD 50 decompensated cirrhosis 50 bioavailable testosterone 50 Baseline characteristics 50 longitudinal cohort 50 Functional Assessment 50 Tasigna prolongs 50 inhospital 50 rheumatologic 50 edifoligide E2F Decoy 50 Allogeneic 50 multicenter trials 50 Elitek 50 axillary lymph node 50 secondary hyperparathyroidism 50 EDSS scores 50 recurrent miscarriage 50 endoscopic mucosal resection 50 chronic eosinophilic leukemia 50 neuropsychological assessment 50 depressive symptomatology 50 SYNTAX trial 50 Modifiable 50 Tigecycline 50 pheochromocytoma 50 adenoma detection 50 HCV antibody 50 Fibroblast 50 anthropometric measures 50 TMJD 50 pulmonary artery hypertension 50 recurrent sinusitis 50 NAbs 50 coronary interventions 50 postoperative delirium 50 Nonclinical 50 transcatheter aortic valve implantation 50 transthyretin amyloidosis 50 EGFR HER2 50 N. gonorrhoeae 50 Warfarin Coumadin 50 atherosclerotic disease 50 interventional cardiac 50 NeuroStar TMS Therapy 50 Y BOCS 50 prenatally diagnosed 50 alpha1 antitrypsin deficiency 50 symptomatic DVT 50 NATRECOR R 50 myopathy rhabdomyolysis 50 prospective multicentre 50 PHPT 50 enteroviral infection 50 LHRH receptor positive 50 Main Outcome Measure 50 molar pregnancy 50 microvascular disease 50 microbiologically evaluable 50 epithelial ovarian 50 CINTREDEKIN BESUDOTOX 50 somatic mutations 50 grade squamous intraepithelial 50 ASCUS 50 nonepileptic seizures 50 Adult Stem Cell Therapy 50 NSTE ACS 50 Percutaneous Tibial Nerve Stimulation 50 neuroendocrine carcinoma 50 cytopenias 50 cerebral somatic oximeter 50 nonalcoholic steatohepatitis NASH 50 empiric therapy 50 TMPRSS2 ERG 50 ADCS CGIC 50 intracerebral haemorrhage 50 hepatocellular carcinomas 50 pharmacologic intervention 50 Lymphoid 50 www.ClinicalTrials.gov 50 invasive carcinoma 50 heparin induced thrombocytopenia 50 autologous platelet gel 50 neuropathologic 49 histologic subtypes 49 nonsurgical treatment 49 mTOR inhibitors 49 SLN biopsy 49 Actinic Keratosis 49 tumor resection 49 EEG recordings 49 REPLACE Registry 49 CRMD 49 fetal malformations 49 FFR guided 49 EXJADE 49 invasive lobular carcinoma 49 immunostaining 49 DNA methylation markers 49 TNF antagonist 49 inhaled corticosteroid therapy 49 endometrioid 49 cardiac allograft vasculopathy 49 polidocanol 49 pelvic lymphadenectomy 49 adjuvant cisplatin 49 Meningiomas 49 pathophysiological processes 49 FDG PET scans 49 intraepithelial neoplasia 49 lymphoid malignancies 49 intrahepatic cholangiocarcinoma 49 situ LCIS 49 retrospective cohort 49 TRUS biopsy 49 ALTE 49 methotrexate monotherapy 49 coagulation assays 49 prostate adenocarcinoma 49 predictive validity 49 beta blocker therapy 49 nonfasting triglyceride levels 49 vascular endothelial dysfunction 49 Percutaneous Coronary Interventions 49 subclinical disease 49 AMOR IPAT 49 bFGF 49 gastric corpus 49 Endometrial 49 squamous cell carcinoma SCC 49 nodal dissection 49 pulmonary exacerbations 49 arterial thickening 49 GERD migraine headaches 49 immunoreactive 49 antiplatelet therapies 49 Combidex 49 androgen suppression 49 Subgroup analyzes 49 MDRD 49 recurrent NSCLC 49 hematologic abnormalities 49 Interbody Fusion 49 plasma adiponectin 49 sternal wound infections 49 independent prognostic marker 49 nucleotide substitutions 49 genomic alterations 49 histologic diagnosis 49 androgen deprivation 49 immunofluorescence staining 49 ductal lobular 49 rFVIIa 49 NPM1 mutation 49 Breast conserving 49 Radical prostatectomy 49 predialysis 49 Non inferiority 49 percutaneous ablation 49 biochemical relapse 49 neoadjuvant setting 49 Symptom severity 49 nonpharmacologic 49 Mantoux test 49 carcinoid tumors 49 symptomatic hyponatremia 49 ICD implantation 49 vincristine doxorubicin 49 hsCRP levels 49 serum markers 49 pulmonary hypertension PH 49 S aureus 49 Lymph node 49 bone density measurements 49 LATITUDE Patient Management 49 antibody titer 49 Humate P 49 ER CHOP 49 CPAP adherence 49 Sociodemographic